In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
January 17th, 2006 | 28 | No |
Popular Name: MEDROXYPROGESTERONE ACETATE MEDROXYPROGESTERONE ACETATE
(6alpha,9xi,14xi)-6-methyl-3,20-dioxopregn-4-en-17-yl acetate
CPD000653524; Depo-provera; Medroxyprogesterone 17-acetate; SAM002564220
CPD000653524; Medroxyprogesterone 17-acetate; SAM002564220
INN); Medroxyprogesterone acetate (FDA
INN); Medroxyprogesterone Acetate (JAN
Medroxyprogesterone 17-acetate
Medroxyprogesterone 17-acetate, MPA
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 4.04 | 11.72 | -14.72 | 0 | 4 | 0 | 60 | 386.532 | 3 | ↓ |
Note Type | Comments | Provided By |
---|---|---|
biological_use | Used as an injectable contraceptive | ZereneX Building Blocks |
Purity | 97% | APIChem |
Patent Database Links | EP1535618; EP1537858; EP1538164; EP1580188; EP1717247; EP1800666; EP1857110; EP1862167; EP1900742; EP1946777; EP1990342; US2002028799; US2005054656; US2005130980; US2005131005; US2005165039; US2005176772; US2005187267; US2006014755; US2006035945; US200603 | ChEBI |
Target | Estrogen/progestogen Receptor | Selleck Chemicals |
mechanism | Gonadotropin secretion inhibitor | IBScreen Bioactives |
PUBCHEM_SUBSTANCE_COMMENT | NCC_SAMPLE_SUPPLIER : LightBiologicals; NCC_SUPPLIER_STRUCTURE_ID : M-2594; NCC_SUPPLIER_SAMPLE_COMMENTS : WHITE POWDER | NIH Clinical Collection via PubChem |
mechanism | Progestogen | IBScreen Bioactives IBScreen Bioactives |
PUBCHEM_SUBSTANCE_COMMENT | SAMPLE_SUPPLIER: LightBiologicals; SUPPLIER_STRUCTURE_ID: M-2594; SUPPLIER_COMMENTS: WHITE POWDER | NIH Clinical Collection via PubChem |
biological_use | Used as an injectable contraceptive | IBScreen Bioactives |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
ANDR-2-E | Androgen Receptor (cluster #2 Of 4), Eukaryotic | Eukaryotes | 3 | 0.43 | Binding ≤ 10μM |
ANDR-2-E | Androgen Receptor (cluster #2 Of 4), Eukaryotic | Eukaryotes | 6 | 0.41 | Binding ≤ 10μM |
ANDR-2-E | Androgen Receptor (cluster #2 Of 4), Eukaryotic | Eukaryotes | 6 | 0.41 | Binding ≤ 10μM |
ESR1-2-E | Estrogen Receptor Alpha (cluster #2 Of 5), Eukaryotic | Eukaryotes | 924 | 0.30 | Binding ≤ 10μM |
ESR2-2-E | Estrogen Receptor Beta (cluster #2 Of 4), Eukaryotic | Eukaryotes | 924 | 0.30 | Binding ≤ 10μM |
GCR-2-E | Glucocorticoid Receptor (cluster #2 Of 2), Eukaryotic | Eukaryotes | 10 | 0.40 | Binding ≤ 10μM |
GCR-2-E | Glucocorticoid Receptor (cluster #2 Of 2), Eukaryotic | Eukaryotes | 13 | 0.39 | Binding ≤ 10μM |
GCR-2-E | Glucocorticoid Receptor (cluster #2 Of 2), Eukaryotic | Eukaryotes | 13 | 0.39 | Binding ≤ 10μM |
MCR-1-E | Mineralocorticoid Receptor (cluster #1 Of 2), Eukaryotic | Eukaryotes | 1197 | 0.30 | Binding ≤ 10μM |
PRGR-1-E | Progesterone Receptor (cluster #1 Of 3), Eukaryotic | Eukaryotes | 0 | 0.00 | Binding ≤ 10μM |
PRGR-1-E | Progesterone Receptor (cluster #1 Of 3), Eukaryotic | Eukaryotes | 11 | 0.40 | Binding ≤ 10μM |
PRGR-1-E | Progesterone Receptor (cluster #1 Of 3), Eukaryotic | Eukaryotes | 11 | 0.40 | Binding ≤ 10μM |
ANDR-2-E | Androgen Receptor (cluster #2 Of 3), Eukaryotic | Eukaryotes | 6 | 0.41 | Functional ≤ 10μM |
ANDR-2-E | Androgen Receptor (cluster #2 Of 3), Eukaryotic | Eukaryotes | 6 | 0.41 | Functional ≤ 10μM |
ESR1-2-E | Estrogen Receptor Alpha (cluster #2 Of 3), Eukaryotic | Eukaryotes | 924 | 0.30 | Functional ≤ 10μM |
ESR1-2-E | Estrogen Receptor Alpha (cluster #2 Of 3), Eukaryotic | Eukaryotes | 924 | 0.30 | Functional ≤ 10μM |
ESR2-1-E | Estrogen Receptor Beta (cluster #1 Of 2), Eukaryotic | Eukaryotes | 924 | 0.30 | Functional ≤ 10μM |
ESR2-1-E | Estrogen Receptor Beta (cluster #1 Of 2), Eukaryotic | Eukaryotes | 924 | 0.30 | Functional ≤ 10μM |
GCR-2-E | Glucocorticoid Receptor (cluster #2 Of 2), Eukaryotic | Eukaryotes | 10 | 0.40 | Functional ≤ 10μM |
GCR-2-E | Glucocorticoid Receptor (cluster #2 Of 2), Eukaryotic | Eukaryotes | 10 | 0.40 | Functional ≤ 10μM |
MCR-2-E | Mineralocorticoid Receptor (cluster #2 Of 2), Eukaryotic | Eukaryotes | 1197 | 0.30 | Functional ≤ 10μM |
MCR-2-E | Mineralocorticoid Receptor (cluster #2 Of 2), Eukaryotic | Eukaryotes | 1197 | 0.30 | Functional ≤ 10μM |
PRGR-2-E | Progesterone Receptor (cluster #2 Of 2), Eukaryotic | Eukaryotes | 0 | 0.00 | Functional ≤ 10μM |
PRGR-2-E | Progesterone Receptor (cluster #2 Of 2), Eukaryotic | Eukaryotes | 1 | 0.45 | Functional ≤ 10μM |
PRGR-2-E | Progesterone Receptor (cluster #2 Of 2), Eukaryotic | Eukaryotes | 10000 | 0.25 | Functional ≤ 10μM |
Z80712-2-O | T47D (Breast Carcinoma Cells) (cluster #2 Of 2), Other | Other | 11 | 0.40 | Binding ≤ 10μM |
Z80712-1-O | T47D (Breast Carcinoma Cells) (cluster #1 Of 7), Other | Other | 0 | 0.00 | Functional ≤ 10μM |
Z80712-1-O | T47D (Breast Carcinoma Cells) (cluster #1 Of 7), Other | Other | 1 | 0.45 | Functional ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
ANDR_MOUSE | P19091 | Androgen Receptor, Mouse | 6.1 | 0.41 | Binding ≤ 1μM |
ANDR_HUMAN | P10275 | Androgen Receptor, Human | 2.9 | 0.43 | Binding ≤ 1μM |
ESR1_HUMAN | P03372 | Estrogen Receptor Alpha, Human | 924 | 0.30 | Binding ≤ 1μM |
ESR2_HUMAN | Q92731 | Estrogen Receptor Beta, Human | 924 | 0.30 | Binding ≤ 1μM |
GCR_HUMAN | P04150 | Glucocorticoid Receptor, Human | 13.2 | 0.39 | Binding ≤ 1μM |
PRGR_HUMAN | P06401 | Progesterone Receptor, Human | 0.34 | 0.47 | Binding ≤ 1μM |
Z80712 | Z80712 | T47D (Breast Carcinoma Cells) | 10.8 | 0.40 | Binding ≤ 1μM |
ANDR_MOUSE | P19091 | Androgen Receptor, Mouse | 6.1 | 0.41 | Binding ≤ 10μM |
ANDR_HUMAN | P10275 | Androgen Receptor, Human | 2.9 | 0.43 | Binding ≤ 10μM |
ESR1_HUMAN | P03372 | Estrogen Receptor Alpha, Human | 924 | 0.30 | Binding ≤ 10μM |
ESR2_HUMAN | Q92731 | Estrogen Receptor Beta, Human | 924 | 0.30 | Binding ≤ 10μM |
GCR_HUMAN | P04150 | Glucocorticoid Receptor, Human | 13.2 | 0.39 | Binding ≤ 10μM |
MCR_HUMAN | P08235 | Mineralocorticoid Receptor, Human | 1197 | 0.30 | Binding ≤ 10μM |
PRGR_HUMAN | P06401 | Progesterone Receptor, Human | 0.34 | 0.47 | Binding ≤ 10μM |
Z80712 | Z80712 | T47D (Breast Carcinoma Cells) | 10.8 | 0.40 | Binding ≤ 10μM |
ANDR_HUMAN | P10275 | Androgen Receptor, Human | 6.1 | 0.41 | Functional ≤ 10μM |
ESR1_HUMAN | P03372 | Estrogen Receptor Alpha, Human | 924 | 0.30 | Functional ≤ 10μM |
ESR2_HUMAN | Q92731 | Estrogen Receptor Beta, Human | 924 | 0.30 | Functional ≤ 10μM |
GCR_HUMAN | P04150 | Glucocorticoid Receptor, Human | 10 | 0.40 | Functional ≤ 10μM |
MCR_HUMAN | P08235 | Mineralocorticoid Receptor, Human | 1197 | 0.30 | Functional ≤ 10μM |
PRGR_HUMAN | P06401 | Progesterone Receptor, Human | 0.15 | 0.49 | Functional ≤ 10μM |
Z80712 | Z80712 | T47D (Breast Carcinoma Cells) | 0.1 | 0.50 | Functional ≤ 10μM |
Description | Species |
---|---|
BMAL1:CLOCK,NPAS2 activates circadian gene expression | |
Nuclear Receptor transcription pathway | |
Nuclear signaling by ERBB4 |
No pre-computed analogs available. Try a structural similarity search.